Epstein Secrets

imes.corn/2020/11/24/world/sputnik-vaccine-russia.html> (11124, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

ricature as `globalist." According to Politico <https://www.politico.com/news/2020/11/24/biden- cabinet-picks-progressives-440463> (11/24, Otterbein, Barron-Lopez, 4.29M), "Progressives don't love Joe Biden's first round of Cabinet picks. But they can live with them." In his Washington Post <https://www.washi

of the first vaccines to the blockaded coastal area." Initially, "former health ministers and several medical workers were inoculated with Russia's Sputnik V jabs in front of dozens of cameras." Next, "medical workers and patients with chronic diseases are to start receiving injections on Tuesday." The

ion tries to leverage trillions of dollars in relief funds to help a battered American economy recover from the pandemic." However, Politico (2/22, Barron-Lopez, Cadelago, 6.73M) says women's rights activists "and allied Democrats are growing increasingly vocal about what they call the unfair targeting of w

the announcement "came shortly after news emerged that he would speak with Russian President Vladimir Putin on Monday about obtaining doses of the Sputnik V COVID-19 vaccine." The AP adds, "Other Latin American leaders who have tested positive for the coronavirus are Brazil's President Jair Bolsonaro,

rts news to Cubans, also resigned, USAGM confirmed." Senators Express Concern About Biden Relief Plan's Stimulus Payments. In what Politico (1/24, Barron-Lopez, Everett, 6.73M) describes as "an opening setback in the new administration's complex pandemic negotiations with Congress," in a call with White Hou

tgoing Trump Administration." While the New York Times (11/24, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

ticist with precisely the sort of pedigreed background that right-wing populists caricature as `globalist." According to Politico (11/24, Otterbein, Barron-Lopez, 4.29M), "Progressives don't love Joe Biden's first round of Cabinet picks. But they can live with them." In his Washington Post (11/24, 14.2M) col

uced Batch Of Sputnik V. Reuters (5/20) reports that Brazilian pharmaceutical company Uniao Quimica "completed production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia." Russia's Gamaleya Institute "said it had seen to quality control

in, Subscription Publication, 8.41M) provides similar coverage. Politico Analysis: Biden Has Moved Leftward On Taxes And Spending. Politico (5/20, Barron-Lopez, 6.73M) reports that "moderate Democrats who worked alongside Joe Biden for decades say the new president's economic policies don't square with the